Traders have circulated a Chinese language post related to medical device approval documents that has been attributed as the reason for the early strength in ThermoGenesis shares, which are up 8c, or 10% to 89c approaching 10 am ET.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on THMO:
- ThermoGenesis files $30M mixed securities shelf
- ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
- Is THMO a Buy, Before Earnings?
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue